{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:19:40Z","timestamp":1792783180762,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz","id":[{"id":"https:\/\/ror.org\/04jhswv08","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The genus\n                    <jats:italic>Mycobacterium<\/jats:italic>\n                    comprises nontuberculous mycobacteria (NTM), which are opportunistic environmental pathogens primarily associated with chronic lung disease. Among current therapeutic options, tigecycline has emerged as a promising alternative for treating NTM due to its broad spectrum of activity, including efficacy against certain mycobacterial species. In this review, we compiled 28 studies investigating the mechanisms and prevalence of tigecycline resistance in NTM. The evidence suggests that tigecycline is less impacted by the monooxygenase MabTetX, the principal tetracycline resistance determinant in\n                    <jats:italic>M. abscessus<\/jats:italic>\n                    . However, adaptive mechanisms, such as WhiB7 regulation, alterations in the\n                    <jats:italic>sigH\u2013rshA<\/jats:italic>\n                    axis, and overexpression of efflux pumps (MmpL), can increase the minimum inhibitory concentration (MIC). In contrast, slow-growing NTM species, including\n                    <jats:italic>M. avium<\/jats:italic>\n                    and\n                    <jats:italic>M. kansasii<\/jats:italic>\n                    , exhibit low intrinsic susceptibility, reflected by high MIC values. We conclude that tigecycline is a promising component of combination of regimens for rapid-growing NTM, although its efficacy against slow-growing species remains limited and standardized breakpoints have not yet been established. .\n                  <\/jats:p>","DOI":"10.1007\/s11033-026-12747-1","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:17:05Z","timestamp":1790504225000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A review of tigecycline resistance in nontuberculous mycobacteria"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5107-3459","authenticated-orcid":false,"given":"Camila da Silva","family":"Moura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0350-2308","authenticated-orcid":false,"given":"William Marco Vicente","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4183-5915","authenticated-orcid":false,"given":"Jesus Pais","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,27]]},"reference":[{"issue":"5\u20136","key":"12747_CR1","doi-asserted-by":"publisher","first-page":"611","DOI":"10.4103\/ijmr.IJMR_2564_21","volume":"153","author":"SK Sharma","year":"2021","unstructured":"Sharma SK, Mohan A (2021) Tuberculosis: from an incurable scourge to a curable disease - journey over millennia. Indian J Med Res 153(5\u20136):611\u2013625. https:\/\/doi.org\/10.4103\/ijmr.IJMR_2564_21","journal-title":"Indian J Med Res"},{"issue":"1","key":"12747_CR2","doi-asserted-by":"publisher","first-page":"100017","DOI":"10.1016\/j.clinme.2024.100017","volume":"24","author":"K Kumar","year":"2024","unstructured":"Kumar K, Ponnuswamy A, Capstick T et al (2024) Non-tuberculous mycobacterial pulmonary disease (NTM-PD): epidemiology, diagnosis and management. Clin Med (Lond) 24(1):100017. https:\/\/doi.org\/10.1016\/j.clinme.2024.100017","journal-title":"Clin Med (Lond)"},{"key":"12747_CR3","unstructured":"Nardell EA Nontuberculous mycobacterial infections. MSD Manual Professional Edition [Internet]. 2022 [cited 2026 Aug 6]. https:\/\/www.msdmanuals.com\/professional\/infectious-diseases\/mycobacteria\/nontuberculous-mycobacterial-infections"},{"key":"12747_CR4","doi-asserted-by":"publisher","first-page":"1289456","DOI":"10.3389\/fpubh.2024.1289456","volume":"12","author":"Y Ning","year":"2024","unstructured":"Ning Y, Ma X, Xu C et al (2024) Global burden of non-tuberculous mycobacterial disease: a systematic analysis. Front Public Health 12:1289456. https:\/\/doi.org\/10.3389\/fpubh.2024.1289456","journal-title":"Front Public Health"},{"issue":"2","key":"12747_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.idc.2023.02.004","volume":"37","author":"E Terhalle","year":"2023","unstructured":"Terhalle E, Schmid A, Guler R et al (2023) Clinical manifestations of nontuberculous mycobacterial infections. Infect Dis Clin North Am 37(2):231\u2013252. https:\/\/doi.org\/10.1016\/j.idc.2023.02.004","journal-title":"Infect Dis Clin North Am"},{"issue":"9","key":"12747_CR6","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3390\/pathogens10091123","volume":"10","author":"A Gon\u00e7alves","year":"2021","unstructured":"Gon\u00e7alves A, Leite C, Meneghello LP et al (2021) Biofilm formation and antimicrobial resistance in nontuberculous mycobacteria. Pathogens 10(9):1123. https:\/\/doi.org\/10.3390\/pathogens10091123","journal-title":"Pathogens"},{"key":"12747_CR7","unstructured":"Centers for Disease Control and Prevention (CDC) Nontuberculous mycobacteria (NTM) infections \u2013 clinical overview [Internet]. 2021 [cited 2026 May 6]. https:\/\/www.cdc.gov\/nontuberculous-mycobacteria\/index.html"},{"issue":"6313","key":"12747_CR8","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1126\/science.aaf8156","volume":"354","author":"JM Bryant","year":"2016","unstructured":"Bryant JM, Grogono DM, Rodriguez-Rincon D et al (2016) Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium. Science 354(6313):751\u2013757. https:\/\/doi.org\/10.1126\/science.aaf8156","journal-title":"Science"},{"issue":"4","key":"12747_CR9","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ccm.2023.08.012","volume":"44","author":"DR Prevots","year":"2023","unstructured":"Prevots DR, Marshall JE, Wagner D et al (2023) Global epidemiology of nontuberculous mycobacterial pulmonary disease. Clin Chest Med 44(4):675\u2013721. https:\/\/doi.org\/10.1016\/j.ccm.2023.08.012","journal-title":"Clin Chest Med"},{"key":"12747_CR10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ijid.2022.10.013","volume":"125","author":"VN Dahl","year":"2022","unstructured":"Dahl VN, M\u00f8lhave M, Fl\u00f8e A, van Ingen J, Sch\u00f6n T, Lillebaek T et al (2022) Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review. Int J Infect Dis 125:120\u2013131. https:\/\/doi.org\/10.1016\/j.ijid.2022.10.013","journal-title":"Int J Infect Dis"},{"issue":"1","key":"12747_CR11","doi-asserted-by":"publisher","first-page":"2000535","DOI":"10.1183\/13993003.00535-2020","volume":"56","author":"CL Daley","year":"2020","unstructured":"Daley CL, Iaccarino JM, Lange C et al (2020) Treatment of nontuberculous mycobacterial pulmonary disease: clinical practice guideline. Eur Respir J 56(1):2000535. https:\/\/doi.org\/10.1183\/13993003.00535-2020","journal-title":"Eur Respir J"},{"issue":"2","key":"12747_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/biology10020096","volume":"10","author":"S Saxena","year":"2021","unstructured":"Saxena S, Spaink HP, Forn-Cun\u00ed G (2021) Drug resistance in nontuberculous mycobacteria: mechanisms and models. Biology 10(2):96. https:\/\/doi.org\/10.3390\/biology10020096","journal-title":"Biology"},{"issue":"5","key":"12747_CR13","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s40265-022-01725-6","volume":"82","author":"GG Zhanel","year":"2022","unstructured":"Zhanel GG, Cheung D, Adam H et al (2022) Review of tigecycline: a glycylcycline antimicrobial. Drugs 82(5):511\u2013542. https:\/\/doi.org\/10.1007\/s40265-022-01725-6","journal-title":"Drugs"},{"issue":"4","key":"12747_CR14","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s12223-023-01070-4","volume":"68","author":"YA Helmy","year":"2023","unstructured":"Helmy YA, Taha-Abdelaziz K, El-Habashi N et al (2023) Antimicrobial resistance in non-tuberculous mycobacteria: mechanisms and therapeutic implications. Folia Microbiol (Praha) 68(4):511\u2013528. https:\/\/doi.org\/10.1007\/s12223-023-01070-4","journal-title":"Folia Microbiol (Praha)"},{"issue":"6","key":"12747_CR15","doi-asserted-by":"publisher","first-page":"e01562","DOI":"10.1128\/aac.01562-22","volume":"67","author":"E Giannoni","year":"2023","unstructured":"Giannoni E, Kahl BC, Bragonzi A et al (2023) Genetic determinants of antimicrobial resistance in Mycobacterium abscessus. Antimicrob Agents Chemother 67(6):e01562\u2013e01522. https:\/\/doi.org\/10.1128\/aac.01562-22","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"12747_CR16","doi-asserted-by":"publisher","first-page":"e00038","DOI":"10.1128\/CMR.00038-18","volume":"32","author":"BA Brown-Elliott","year":"2019","unstructured":"Brown-Elliott BA, Wallace RJ Jr (2019) Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of non-tuberculous mycobacteria. Clin Microbiol Rev 32(3):e00038\u2013e00018. https:\/\/doi.org\/10.1128\/CMR.00038-18","journal-title":"Clin Microbiol Rev"},{"issue":"11","key":"12747_CR17","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1080\/17476348.2023.2283135","volume":"17","author":"KA Hamed","year":"2023","unstructured":"Hamed KA, Tillotson G (2023) A review of nontuberculous mycobacterial pulmonary disease: epidemiology, diagnosis, and treatment. Expert Rev Respir Med 17(11):973\u2013988. https:\/\/doi.org\/10.1080\/17476348.2023.2283135","journal-title":"Expert Rev Respir Med"},{"issue":"1","key":"12747_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41533-024-00403-9","volume":"34","author":"DJ Dhasmana","year":"2024","unstructured":"Dhasmana DJ, Bano G, Dheda K et al (2024) Diagnosis and management of non-tuberculous mycobacterial pulmonary disease. NPJ Prim Care Respir Med 34(1):45. https:\/\/doi.org\/10.1038\/s41533-024-00403-9","journal-title":"NPJ Prim Care Respir Med"},{"key":"12747_CR19","doi-asserted-by":"publisher","first-page":"1410672","DOI":"10.3389\/fpubh.2024.1410672","volume":"12","author":"H Zhang","year":"2024","unstructured":"Zhang H, Tang M, Li D, Xu M, Ao Y, Lin L (2024) Applications and advances in molecular diagnostics: revolutionizing non-tuberculous mycobacteria species and subspecies identification. Front Public Health 12:1410672. https:\/\/doi.org\/10.3389\/fpubh.2024.1410672","journal-title":"Front Public Health"},{"issue":"1","key":"12747_CR20","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1080\/07853890.2022.2121984","volume":"54","author":"SY Kim","year":"2022","unstructured":"Kim SY, Koh WJ (2022) Antimicrobial susceptibility of non-tuberculous mycobacteria: an update. Ann Med 54(1):2345\u20132358. https:\/\/doi.org\/10.1080\/07853890.2022.2121984","journal-title":"Ann Med"},{"issue":"5","key":"12747_CR21","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ijantimicag.2014.01.018","volume":"43","author":"Q Guo","year":"2014","unstructured":"Guo Q, Liu W, Wu J et al (2014) In vitro antimicrobial susceptibility of rapidly growing mycobacteria to tigecycline and other antimicrobial agents. Int J Antimicrob Agents 43(5):446\u2013450. https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.01.018","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"12747_CR22","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1128\/AAC.46.10.3164-3167.2002","volume":"46","author":"RJ Wallace Jr","year":"2002","unstructured":"Wallace RJ Jr, Brown-Elliott BA, Crist CJ et al (2002) Comparison of the in vitro activity of the glycylcycline tigecycline (GAR-936) with those of tetracycline, minocycline and doxycycline against isolates of nontuberculous mycobacteria. Antimicrob Agents Chemother 46(10):3164\u20133167. https:\/\/doi.org\/10.1128\/AAC.46.10.3164-3167.2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"12747_CR23","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/antibiotics11050572","volume":"11","author":"HF Ng","year":"2022","unstructured":"Ng HF, Ngeow YF (2022) Genetic determinants of tigecycline resistance in Mycobacteroides abscessus. Antibiot (Basel) 11(5):572. https:\/\/doi.org\/10.3390\/antibiotics11050572","journal-title":"Antibiot (Basel)"},{"issue":"6","key":"12747_CR24","doi-asserted-by":"publisher","first-page":"e00119","DOI":"10.1128\/AAC.00119-18","volume":"62","author":"P Rudra","year":"2018","unstructured":"Rudra P, Hurst-Hess K, Cotten KL et al (2018) Intrinsic resistance to tetracyclines in Mycobacterium abscessus is mediated by a flavin-dependent monooxygenase. Antimicrob Agents Chemother 62(6):e00119\u2013e00118. https:\/\/doi.org\/10.1128\/AAC.00119-18","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"12747_CR25","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1093\/jac\/dkac165","volume":"77","author":"S Singh","year":"2022","unstructured":"Singh S, Verma R, Sharma S et al (2022) Role of MabTetX in tetracycline resistance and its interaction with tigecycline in Mycobacterium abscessus. J Antimicrob Chemother 77(8):2156\u20132164. https:\/\/doi.org\/10.1093\/jac\/dkac165","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"12747_CR26","doi-asserted-by":"publisher","first-page":"e01353","DOI":"10.1128\/AAC.01353-17","volume":"61","author":"K Hurst-Hess","year":"2017","unstructured":"Hurst-Hess K, Rudra P, Ghosh P (2017) Mycobacterium abscessus WhiB7 regulates a species-specific repertoire of genes to confer extreme antibiotic resistance. Antimicrob Agents Chemother 61(11):e01353\u2013e01317. https:\/\/doi.org\/10.1128\/AAC.01353-17","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"12747_CR27","doi-asserted-by":"publisher","first-page":"e1011060","DOI":"10.1371\/journal.pgen.1011060","volume":"19","author":"K Hurst-Hess","year":"2023","unstructured":"Hurst-Hess K, McManaman C, Yang Y et al (2023) WhiB7-mediated transcriptional response to antibiotic stress in Mycobacterium abscessus. PLoS Genet 19(6):e1011060. https:\/\/doi.org\/10.1371\/journal.pgen.1011060","journal-title":"PLoS Genet"},{"issue":"12","key":"12747_CR28","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1099\/jmm.0.000834","volume":"67","author":"HF Ng","year":"2018","unstructured":"Ng HF, Ngeow YF, Yap SF et al (2018) Mutation in the anti-sigma factor MAB_3542c (rshA) is associated with tigecycline resistance in Mycobacterium abscessus. J Med Microbiol 67(12):1676\u20131681. https:\/\/doi.org\/10.1099\/jmm.0.000834","journal-title":"J Med Microbiol"},{"issue":"1","key":"12747_CR29","doi-asserted-by":"publisher","first-page":"151380","DOI":"10.1016\/j.ijmm.2019.151380","volume":"310","author":"HF Ng","year":"2020","unstructured":"Ng HF, Ngeow YF, Yap SF et al (2020) Tigecycline resistance may be associated with dysregulated response to stress in Mycobacterium abscessus. Int J Med Microbiol 310(1):151380. https:\/\/doi.org\/10.1016\/j.ijmm.2019.151380","journal-title":"Int J Med Microbiol"},{"issue":"6","key":"12747_CR30","doi-asserted-by":"publisher","first-page":"001536","DOI":"10.1099\/jmm.0.001536","volume":"71","author":"KM Aw","year":"2022","unstructured":"Aw KM, Ngeow YF, Ng HF (2022) Mutations in rshA contribute to tigecycline resistance in Mycobacteroides abscessus. J Med Microbiol 71(6):001536. https:\/\/doi.org\/10.1099\/jmm.0.001536","journal-title":"J Med Microbiol"},{"key":"12747_CR31","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jgar.2022.10.015","volume":"31","author":"SE Mudde","year":"2022","unstructured":"Mudde SE, van der Woude AD, Coolen JPM et al (2022) Efflux pumps in Mycobacterium abscessus and their role in antimicrobial resistance. J Glob Antimicrob Resist 31:345\u2013352. https:\/\/doi.org\/10.1016\/j.jgar.2022.10.015","journal-title":"J Glob Antimicrob Resist"},{"issue":"7","key":"12747_CR32","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/1440-1681.13777","volume":"50","author":"A Li","year":"2023","unstructured":"Li A, Tan Z, He S, Chu H (2023) In vitro susceptibility of tetracyclines against non-tuberculous mycobacteria in China. Clin Exp Pharmacol Physiol 50(7):604\u2013609. https:\/\/doi.org\/10.1111\/1440-1681.13777","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"178","key":"12747_CR33","doi-asserted-by":"publisher","first-page":"250038","DOI":"10.1183\/16000617.0038-2025","volume":"34","author":"CL Daley","year":"2025","unstructured":"Daley CL, Flume PA, van Ingen J et al (2025) A systematic review of tetracyclines for nontuberculous mycobacteria: focus on tigecycline. Eur Respir Rev 34(178):250038. https:\/\/doi.org\/10.1183\/16000617.0038-2025","journal-title":"Eur Respir Rev"},{"issue":"1","key":"12747_CR34","doi-asserted-by":"publisher","first-page":"e01509","DOI":"10.1128\/AAC.01509-21","volume":"66","author":"JA Schildkraut","year":"2022","unstructured":"Schildkraut JA, Coolen JPM, Burggraaf AM et al (2022) Antibiotic tolerance in Mycobacterium abscessus: a transcriptomic perspective. Antimicrob Agents Chemother 66(1):e01509\u2013e01521. https:\/\/doi.org\/10.1128\/AAC.01509-21","journal-title":"Antimicrob Agents Chemother"},{"issue":"34","key":"12747_CR35","doi-asserted-by":"publisher","first-page":"12200","DOI":"10.1073\/pnas.0505446102","volume":"102","author":"RP Morris","year":"2005","unstructured":"Morris RP, Nguyen L, Gatfield J et al (2005) Ancestral antibiotic resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 102(34):12200\u201312205. https:\/\/doi.org\/10.1073\/pnas.0505446102","journal-title":"Proc Natl Acad Sci USA"},{"key":"12747_CR36","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1471-2180-12-152","volume":"12","author":"K Buri\u00e1n","year":"2012","unstructured":"Buri\u00e1n K, Szab\u00f3 AM, Szab\u00f3 Z et al (2012) Transcriptional profile of Mycobacterium smegmatis under tigecycline stress. BMC Microbiol 12:152. https:\/\/doi.org\/10.1186\/1471-2180-12-152","journal-title":"BMC Microbiol"},{"issue":"4","key":"12747_CR37","doi-asserted-by":"publisher","first-page":"001378","DOI":"10.1099\/jmm.0.001378","volume":"70","author":"CL Lee","year":"2021","unstructured":"Lee CL, Ngeow YF, Ng HF (2021) Premature stop mutation in SigH is associated with tigecycline resistance in Mycobacterium abscessus. J Med Microbiol 70(4):001378. https:\/\/doi.org\/10.1099\/jmm.0.001378","journal-title":"J Med Microbiol"},{"issue":"12","key":"12747_CR38","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.3390\/ijms21124191","volume":"21","author":"L Rodrigues","year":"2020","unstructured":"Rodrigues L, Machado D, Couto I, Amaral L, Viveiros M (2020) Efflux pump inhibitors against nontuberculous mycobacteria: a promising strategy. Int J Mol Sci 21(12):4191. https:\/\/doi.org\/10.3390\/ijms21124191","journal-title":"Int J Mol Sci"},{"issue":"3","key":"12747_CR39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/antibiotics8030153","volume":"8","author":"JS Vianna","year":"2019","unstructured":"Vianna JS, Machado D, Ramis IB et al (2019) Verapamil enhances the antimicrobial activity of bedaquiline and clofazimine against Mycobacterium abscessus. Antibiotics 8(3):153. https:\/\/doi.org\/10.3390\/antibiotics8030153","journal-title":"Antibiotics"},{"issue":"4","key":"12747_CR40","doi-asserted-by":"publisher","first-page":"e02454","DOI":"10.1128\/AAC.02454-17","volume":"62","author":"D Machado","year":"2018","unstructured":"Machado D, Couto I, Perdig\u00e3o J et al (2018) Contribution of efflux to the development of tigecycline resistance in Mycobacterium abscessus. Antimicrob Agents Chemother 62(4):e02454\u2013e02417. https:\/\/doi.org\/10.1128\/AAC.02454-17","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12747-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12747-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12747-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:01:56Z","timestamp":1790550116000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12747-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,27]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12747"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12747-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,27]]},"assertion":[{"value":"13 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1637"}}